Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

OSI stock falters on Tarceva sales concerns Shares of OSI Pharmaceuticals Inc. fell sharply Friday on concerns about the newly approved drug #39;s ability to meet sales targets.
